Bleakley Financial Group LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 8.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 80,072 shares of the company’s stock after selling 7,617 shares during the quarter. Bleakley Financial Group LLC’s holdings in Procter & Gamble were worth $12,303,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Procter & Gamble by 0.6% in the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock valued at $36,050,992,000 after purchasing an additional 1,419,322 shares during the last quarter. Geode Capital Management LLC increased its stake in Procter & Gamble by 1.8% in the 2nd quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company’s stock valued at $9,439,341,000 after buying an additional 1,060,713 shares during the last quarter. Norges Bank acquired a new position in shares of Procter & Gamble during the 2nd quarter worth about $5,099,644,000. Charles Schwab Investment Management Inc. boosted its stake in shares of Procter & Gamble by 1.7% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 17,385,571 shares of the company’s stock worth $2,770,035,000 after buying an additional 294,673 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Procter & Gamble by 21.4% in the 2nd quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock valued at $2,608,785,000 after acquiring an additional 2,880,895 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
NYSE PG opened at $160.77 on Friday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $179.99. The stock has a market cap of $373.62 billion, a PE ratio of 23.82, a P/E/G ratio of 5.34 and a beta of 0.38. The firm has a 50-day moving average of $149.02 and a 200-day moving average of $150.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were paid a $1.0568 dividend. The ex-dividend date was Friday, January 23rd. This represents a $4.23 annualized dividend and a yield of 2.6%. Procter & Gamble’s payout ratio is 62.67%.
Insider Transactions at Procter & Gamble
In related news, insider Moses Victor Javier Aguilar sold 15,169 shares of the company’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the transaction, the insider directly owned 44,735 shares in the company, valued at approximately $7,259,595.80. This represents a 25.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,827 shares of Procter & Gamble stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the completion of the sale, the insider owned 12,639 shares of the company’s stock, valued at $2,026,158.09. This trade represents a 50.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 341,260 shares of company stock worth $54,256,985. 0.20% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
PG has been the subject of several recent research reports. UBS Group increased their price target on Procter & Gamble from $161.00 to $170.00 and gave the company a “buy” rating in a research report on Friday, January 23rd. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, December 29th. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a report on Friday, January 16th. Rothschild & Co Redburn increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research note on Friday, January 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, December 8th. Fourteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $168.33.
Read Our Latest Stock Analysis on PG
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
- Five stocks we like better than Procter & Gamble
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold $5,000: The 2026 Gold & Silver Summit is LIVE March 4
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
